Research Article

Ceramide and Related-Sphingolipid Levels Are Not Altered in Disease-Associated Brain Regions of APPSL and APPSL/PS1M146L Mouse Models of Alzheimer's Disease: Relationship with the Lack of Neurodegeneration?

Figure 1

Levels of NFA-ceramides and 2-HFA-ceramides (a–c) and other related-sphingolipids (SM, GalCer, and sulfatides) (d–f) in the cortex, hippocampus, and cerebellum of 24-month-old APPSL mice and age-matched nontransgenic mice. WT: wild-type control mice. Each sphingolipid class was analyzed by HPTLC and their respective concentrations were calculated from standard curves after densitometric scanning of the plates as described under Section 2. Values are expressed as the means ± S.D. and statistically analyzed by a Mann-Whitney test. * compared to the respective wild-type mice.
920958.fig.001a
920958.fig.001b
920958.fig.001c